SUBSTITUTED TRICYCLIC HETEROCYCLIC COMPOUNDS FOR USE AS EGFR INHIBITORS

摘要

This invention relates to novel compounds and processes for their preparation, methods of treating diseases, particularly cancer, comprising administering said compounds, and methods of making pharmaceutical compositions for the treatment or prevention of disorders, particularly cancer.